Industry

MaaT Pharma reports positive Phase 1b results for MaaT033 in ALS, setting the stage for future advances

A significant milestone for both microbiome research and neurodegenerative diseases.

Freya Biosciences secures $10.4 million investment to tackle women’s health challenges

A Bill & Melinda Gates Foundation strategic investment to tackle bacterial vaginosis and improve maternal and neonatal health outcomes worldwide.

From Biofarma Group a probiotic therapy as an adjuvant to cancer immunotherapy

Biofarma Group has launched an innovative project in collaboration with the Department of Surgery, Endocrinology and Gastroenterology of the University of Naples ‘Federico II’, the Centro Sperimentale del Latte (CSL)…

QIAGEN and McGill University partner to drive innovation in microbiome research

Three-year collaboration to pioneer new insights in microbial sciences and health applications.

EnteroBiotix’s EBX-102 shows promising Phase 1b results for liver cirrhosis treatment

New microbiome based therapy demonstrates safety and potential benefits for liver cirrhosis and mental health.

October 2024 review: M&A, licensing, and investments in one place

October 2024 saw notable activity in mergers, acquisitions, and strategic investments within the biotech and life sciences industries.

Codex Committee on Nutrition and Foods for Special Dietary Uses Concludes 44th Session without Adopting Probiotic Guidelines

In the session's conclusion, CCNFSDU agreed to maintain the status quo for the next three to five years rather than start to work on new guidelines.

The gut, conductor of our health. The International Yakult Symposium congress report  

A symphony of microbiome insights: from early infancy to advanced age, the microbiome orchestrates critical processes that affect our health.

Health Canada Authorizes Functional Claim for SynbÆctive® Femme, a Patented Probiotic Formula for Women’s Health

The recently patented probiotic combination specifically focused on women’s urogenital health.

European microbiome leaders unite to accelerate global therapeutic development

The partnership aims to accelerate the development and approval of microbiome-based therapeutics by harmonizing regulatory frameworks.

Subscribe to MicrobiomePost newsletter

Take full advantage of MicrobiomePost‘s features.

Scroll to Top